abor induction with synthetic prostaglandins in obese woma

Not Applicable

Recruiting

• Conditions: Induced labor. Maternal obesity; E04.520.252.968; C13.703.417

• Registration Number: RBR-7xytb6
• Lead Sponsor: niversidade Federal da Paraiba

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-08-19
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Nulliparous or multiparous pregnant obese women; 37 weeks of gestational age; Bishop score less than or equal to 6.

Exclusion Criteria

Multiple babies; Anomalous fetal presentations; Unexplained vaginal bleeding; Abnormal Placentation: Placenta Previa, Vasa Previa or Placenta Accreta; Previous uterine scar; Active liver, kidney, lung or heart disease; systemic or local infectious diseases; allergy to any prostaglandins.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluate the success of cervical ripening in obese pregnant women submited to labor induction with misoprostol and dinoprostone, verified through the evaluation of Bishop score greater or equal to 6.

Secondary Outcome Measures

Name	Time	Method
Evaluate the time between the use of medication and appropriated cervical ripening, based on Bishop score greater or equal to 6.;Evaluate the need of complementary intravenous oxytocin during induction of labor between the groups.;Analyze the rates of cesarian births and vaginal deliveries among the groups by monitoring participants.;Evaluate other outcomes or complications during labor, such as tachysystole, meconium, dystocia and fetal distress.;Evaluate the presence of maternal side effects related to the induction method, defined as the adverse events related to drug composition, such as fever, nausea or vomiting.